Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-10-15

Clinical Trial Update: A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for oxybutynin in urge urinary incontinence; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • oxybutynin (oxybutynin)

Snippet

Sponsor: FemmePharma Global Healthcare, Inc. | Conditions: Urinary Incontinence, Urge | Phase 2 | Status: COMPLETED